- Ashworth, Alan;
- Sawyer, E;
- Roylance, R;
- Petridis, C;
- Brook, MN;
- Nowinski, S;
- Papouli, E;
- Fletcher, O;
- Pinder, S;
- Hanby, A;
- Kohut, K
Invasive lobular breast cancer (ILC) accounts for 10-15% of all invasive breast carcinomas. It is generally ER positive (ER+) and often associated with lobular carcinoma in situ (LCIS). Genome-wide association studies have identified more than 70 common po
